The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.
Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding .
Notice of Funding Opportunities
Title
Sort descending
Announcement Number
Activity Code
Clinical Trials Status Expiration Date Program Official
Cancer Prevention and Control Clinical Trials Grant Program PAR-24-072 (R01 Clinical Trial Required)
R01
Clinical Trial Required
01/08/2027
Brandy Heckman-Stoddard, Ph.D., M.P.H.
Cancer Prevention and Control Clinical Trials Planning Grant Program PAR-22-173 (R34 Clinical Trials Optional)
R34
05/08/2025
Brandy Heckman-Stoddard, Ph.D., M.P.H.
Cancer Prevention and Control Clinical Trials Planning Grant Program PAR-22-174 (U34 Clinical Trials Optional)
U34
05/08/2025
Brandy Heckman-Stoddard, Ph.D., M.P.H.
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research PAR-22-099 (R01 Clinical Trial Optional)
R01
Clinical Trial Optional
05/08/2025
Richard Mazurchuk, Ph.D.
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies PAR-21-329 (R01 Clinical Trial Optional)
R01
Clinical Trial Optional
11/06/2024
Consortium for Palliative Care Research Across the Lifespan RFA-AG-25-002 (U54 Clinical Trial Optional)
U54
Clinical Trial Optional
07/03/2024
Brennan Streck, Ph.D., R.N., M.P.H.
Discovery and Development of Natural Products for Cancer Interception and Prevention RFA-CA-23-028 (UG3/UH3 Clinical Trial Not Allowed)
UH3, UG3
Clinical Trial Not Allowed
06/14/2025
Altaf Mohammed, Ph.D.
HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery NOT-NS-22-095
06/25/2025
Rachel Altshuler, Ph.D.
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment RFA-NS-22-034 (R01 Clinical Trial Not Allowed)
R01
Clinical Trial Not Allowed
12/07/2024
Rachel Altshuler, Ph.D.
HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices RFA-NS-23-003 (RM1 Clinical Trial Optional)
RM1
Clinical Trial Optional
06/10/2025
